ライフサイエンスコーパス: ID

1 ID consultations increased by 40.2% (15.4 consultations

2 ID immunization with cdAMP/Nano-11 expanded the populati

3 ID rabies vaccination induces acceptable antibody titers

4 ID telemedicine practice directed at inpatients appears

5 ID vaccination produced acceptable antibody levels in al

6 ID/HIV physicians and other healthcare professionals adv

7 ID/HIV physicians have a unique frontline perspective to

8 %ID/L was identified as an independent prognostic factor

9 15.37 +/- 5.21 %ID g(-1) and 6.56 +/- 4.03 %ID g(-1), respectively, for (89)Zr-DFO-azepin-onartuzuma

10 1.38 +/- 11.57 %ID g(-1) and 18.84 +/- 6.03 %ID g(-1), respectively, for (89)Zr-DFO-Bn-NCS-onartuzuma

11 with an intact BBB resulted in 3.56 +/- 1.06%ID/g and 3.57 +/- 0.59%ID/g in the same brain regions, r

12 luding 2.9% cardiac death, 3.1% MI, and 5.1% ID-TLR).

13 nt of cell-carriers in the brain, up to 8.1% ID/g, was recorded followed a single intrathecal injecti

14 mL (HemosIL-AcuStar-HIT-IgG) and titer >=16 (ID-H/PF4-PaGIA); cutoffs with 100% NPV were <0.13 U/mL a

15 est lung residence time (AUC(inf) 253 +/- 18 ID/g*hrs) of all TM modalities.

16 oV-2 [Xpert Xpress], Abbott ID NOW COVID-19 [ID NOW], and GenMark ePlex SARS-CoV-2 Test [ePlex]) to d

17 e time (AUC(inf) 141 +/- 3.2 vs 12.4 +/- 4.2 ID/g*hrs for ICAM and 188 +/- 90 vs 34.7 +/- 19.9 ID/g*h

18 ssue [%ID/g]) than of [(68)Ga]Ga-FAPI-04 (2 %ID/g).

19 The ID Now influenza A & B 2 (ID Now) assay (Abbott Laboratories), Cobas influenza A/B

20 injected dose [%ID]) reached 15.37 +/- 5.21 %ID g(-1) and 6.56 +/- 4.03 %ID g(-1), respectively, for

21 sue (%ID/g) in the cortex and 17.09 +/- 7.22%ID/g in subcortical structures.

22 neys, particularly in the first hour (33.25 %ID/g and 207.6 %ID/g, respectively, at 1 h after injecti

23 , as compared with 30.8 mo if lower than 26 %ID (P = 0.008).

24 mo in cases of skeletal uptake that was 26 %ID or higher, as compared with 30.8 mo if lower than 26

25 aving early (by day 3) or late (after day 3) ID intervention, or none.

26 d relatively faster tumor accumulation (~30 %ID/g at 3 h after injection) and lower average kidney up

27 or alphaICAM and 1023 +/- 507 vs. 114 +/- 37 ID/g*hrs for alphaPECAM mAb vs scFv).

28 significantly higher uptake (31.9 vs. 25.4 %ID and 6.0 vs. 4.7 %ID/L; P < 0.02).

29 nt reduction in tumor uptake (6.34 +/- 0.47 %ID g(-1)) of (89)Zr-DFO-azepin-onartuzumab (n = 4).

30 the MI region at d3 (5.9+/-0.9vs 2.4+/-0.5 %ID/cc), decreasing to control level by d7 (4.3+/-0.6 %ID

31 injected dose (%ID) or between 1.8 and 10.5 %ID/1,000 mL of bone volume (%ID/L).

32 NCaP xenografts and a longer retention (4.5 %ID/g vs. 0.9 %ID/g at 168 h).

33 ID/g at 1 h after injection to 7.5 +/- 8.51 %ID/g at 24 h after injection (in the case of CA003).

34 ction) and lower average kidney uptake (<55 %ID/g at both 1 and 3 h after injection).

35 pin-onartuzumab (n = 4) and 21.38 +/- 11.57 %ID g(-1) and 18.84 +/- 6.03 %ID g(-1), respectively, for

36 lted in 3.56 +/- 1.06%ID/g and 3.57 +/- 0.59%ID/g in the same brain regions, respectively.

37 ecreasing to control level by d7 (4.3+/-0.6 %ID/cc).

38 0.6 at 1 h after injection and 5.0 +/- 0.6 %ID/g at 2 h after injection and was dependent on the rad

39 ly in the first hour (33.25 %ID/g and 207.6 %ID/g, respectively, at 1 h after injection), indicating

40 injection (79.3% +/- 4.2% vs 80.4% +/- 10.6% ID/g for alphaICAM and 58.9% +/- 3.6% ID/g vs. 47.7% +/-

41 10.6% ID/g for alphaICAM and 58.9% +/- 3.6% ID/g vs. 47.7% +/- 5.8% ID/g for alphaPECAM mAb vs. scFv

42 SMA-7.3 revealed fast blood clearance (0.63 %ID/g at 1 h after injection), and the highest activity u

43 privately insured individuals below age 65, ID consultations during OPAT are associated with large a

44 peak uptake (104 +/- 20.3 and 70.8 +/- 23.7 %ID/g, respectively) in LNCaP tumor xenografts, and this

45 %ID/g, P < 0.001) and on day 7 (7.8 +/- 3.7 %ID/g vs. 3.0 +/- 0.8 %ID/g, P = 0.006), though the effic

46 r uptake (31.9 vs. 25.4 %ID and 6.0 vs. 4.7 %ID/L; P < 0.02).

47 on day 7 (7.8 +/- 3.7 %ID/g vs. 3.0 +/- 0.8 %ID/g, P = 0.006), though the efficiency of cardiomyocyte

48 M and 58.9% +/- 3.6% ID/g vs. 47.7% +/- 5.8% ID/g for alphaPECAM mAb vs. scFv), but marked difference

49 896 (ID 896), was highly expressed by an emerging meningococc

50 hrs for ICAM and 188 +/- 90 vs 34.7 +/- 19.9 ID/g*hrs for PECAM), despite having similar blood PK, in

51 urve (AUC(inf) 1698 +/- 352 vs. 53.3 +/- 7.9 ID/g*hrs for alphaICAM and 1023 +/- 507 vs. 114 +/- 37 I

52 s and a longer retention (4.5 %ID/g vs. 0.9 %ID/g at 168 h).

53 ntage injected dose [%ID]/g vs. 3.8 +/- 0.9 %ID/g, P < 0.001) and on day 7 (7.8 +/- 3.7 %ID/g vs. 3.0

54 was observed-a decrease from 67.0 +/- 20.9 %ID/g at 1 h after injection to 7.5 +/- 8.51 %ID/g at 24

55 cterized by high tumor uptake (2.56 +/- 0.97%ID/g, 1 h post-injection) and rapid elimination from non

56 kb), 97% were found in each sample (by >98% ID metagenomic read recruitment) to have relative abunda

57 Abbott ID Now performance was similar to RT-LAMP of crude sampl

58 re the results of comparisons between Abbott ID Now COVID-19 and Cepheid Xpert Xpress SARS-CoV-2 usin

59 ansport media and comparisons between Abbott ID Now COVID-19 and Cepheid Xpert Xpress SARS-CoV-2 usin

60 a for Cepheid and dry nasal swabs for Abbott ID Now.

61 ePlex) and point-of-care instruments (Abbott ID NOW).

62 ght to evaluate the recently released Abbott ID Now COVID-19 assay, which is capable of producing pos

63 method of collection and sample type, Abbott ID Now COVID-19 had negative results in a third of the s

64 ert Xpress SARS-CoV-2 [Xpert Xpress], Abbott ID NOW COVID-19 [ID NOW], and GenMark ePlex SARS-CoV-2 T

65 Among a total of 2016 academic ID physicians, there were 742 (37%) women who together a

66 the rank of full professor exist in academic ID, after adjustment for multiple factors known to influ

67 should be made to address equity in academic ID.

68 rces (Gene Expression Omnibus, GEO accession ID: GSE74486).

69 %DeltacTOI significantly differed among ID, IB and DB (P < 0.001), with the latter showing the g

70 etting expectations for best practices among ID divisions across the United States.

71 In the workflow analysis, ID NOW produced the lowest time to result per specimen (

72 ased significantly during DB (P < 0.001) and ID (P < 0.001) compared to IB.

73 cardiac death (4.9% vs. 4.0%; p = 0.003) and ID-TLR (10.9% vs. 10.2%; p = 0.02) compared with men.

74 interval [CI:]: 1.01 to 1.30; p = 0.04) and ID-TLR (HR: 1.23; 95% CI: 1.05 to 1.44; p = 0.009) but n

75 andard (98.3%) followed by ePlex (91.4%) and ID NOW (87.7%).

76 on the m2000 [abbreviated ACOV; Abbott] and ID Now COVID-19 [abbreviated IDNOW; Abbott]) and a labor

77 owed considerable discordance between AD and ID-BMD.

78 the hypotheses that treatment of anemia and ID in HF would improve symptoms and long-term outcomes.

79 nd cognitive deficits reminiscent of ASD and ID phenotypes.

80 motional impairments consistent with ASD and ID.

81 in Arid1b haploinsufficiency-induced ASD and ID.

82 T) interneurons, and examined their ASD- and ID-like behaviors.

83 mutest-HIA-IgG, HemosIL-AcuStar-HIT-IgG, and ID-H/PF4-PaGIA in retrospective (n = 221) and prospectiv

84 trials, women had a higher risk of MACE and ID-TLR compared with men at 5 years following PCI.

85 lex (100% detection at 1,000 copies/ml), and ID NOW (20,000 copies/ml).

86 sociation was identified between El Nino and ID MME occurrence (Z = 0.28, p = .81).

87 T/CT scanner, SUV(max), SUV(mean), CAA, and %ID measured by absolute quantitation of (99m)Tc-pyrophos

88 fic IDs were used to identify potential anti-IDs in the serum.

89 home-based (HB) programs are as effective as ID programs.

90 revealed increased intermembrane spacing at ID sites adjacent to gap junctions (GJs; 64 +/- 9 nm ver

91 specimens from 4,856 individuals from Boise, ID, collected over 1 week in April 2020 as part of the C

92 has the potential to greatly accelerate both ID and AST to inform treatment.

93 pleted cation-adjusted Mueller-Hinton broth (ID-BMD), and agar dilution (AD) using standard Mueller-H

94 ics, such as sociality or trophic level, but ID MMEs did occur more frequently in semiaquatic species

95 ecommendations for ASP interventions made by ID physicians were relayed to primary teams and tracked

96 Here, we present the first U-Pb CA-ID-TIMS zircon age (252.24 +/- 0.11 (2sigma) Ma) from a

97 SUV(max), SUV(mean), CAA, %ID, and visual grade were moderately positively correlat

98 A method to prepare iron-depleted CAMHB (ID-CAMHB) has been described by the Clinical and Laborat

99 llary as the electrospray voltage, capillary ID, and column length were varied.

100 In 121 (17.6%) of 687 unresolved cases, ID-H/PF4-PaGIA was used as second-line testing (addition

101 o from SMILES patterns (such as MetFrag, CFM-ID, and Ms-Finder), the problem of identification is sti

102 predicted by software such as MetFrag or CFM-ID.

103 a unique five plex RT-qPCR test, termed CoV2-ID, that allows the detection of three viral target gene

104 ging to screen image-based phenotypes (CRaft-ID; CRISPR-based microRaft followed by guide RNA identif

105 linical Research Network Portfolio Database (ID number: 31951, 24 April 2017).

106 Absolute or functional iron deficiency (ID) is seen in ~50% patients with HF.

107 ted bradycardia (IB), isolated desaturation (ID) and combined desaturation/bradycardia (DB).

108 ve-virus reciprocal 50% inhibitory dilution (ID(50)) geometric mean titers of 501 in the 10-mug dose

109 by SLM-TIMS, employing the isotope dilution (ID) technique, with very good accuracy and precision.

110 required is called the intrinsic dimension (ID) of the data.

111 ing patients with intellectual disabilities (ID) from transplantation has received growing attention

112 diseases, including intellectual disability (ID) and autism spectrum disorders (ASD).

113 been implicated in intellectual disability (ID) and developmental delay (DD).

114 viduals with severe intellectual disability (ID) and disruptive behavior.

115 common etiology for intellectual disability (ID) and growth disruption.

116 %-3% of unexplained intellectual disability (ID) cases in females and are associated with autism, bra

117 Intellectual disability (ID) is a heterogeneous clinical entity and includes an e

118 varying degrees of intellectual disability (ID) or developmental delay (DD) and short stature.

119 mental delay (GDD), intellectual disability (ID), and motor delay in individuals with cortical abnorm

120 rum disorder (ASD), intellectual disability (ID), and schizophrenia (SZ).

121 n facial phenotype, intellectual disability (ID), distinctive behavioral features, and a seizure diso

122 er characterized by intellectual disability (ID), motor and speech delay, autistic features, hypotoni

123 Intellectual disability (ID), which presents itself during childhood, belongs to

124 disorder (ASD) and intellectual disability (ID).

125 mber 2015 with mandatory infectious disease (ID) consultation for all meropenem and imipenem courses

126 e of providing inpatient infectious disease (ID) consultations using real-time interactive telemedici

127 linical microbiologists, infectious disease (ID) pharmacists, and infectious disease physicians repre

128 impact of these trends, infectious disease (ID) physicians were surveyed regarding their perceptions

129 between female and male infectious diseases (ID) faculty with academic appointments at US medical sch

130 hip in the specialty of infectious diseases (ID) have markedly increased over the last decade, includ

131 Infectious diseases (ID) physicians are increasingly responsible for the mana

132 t the 176-bed hospital, infectious diseases (ID) physicians remotely reviewed patients on broad-spect

133 men faculty in academic Infectious Diseases (ID) remain poorly understood.

134 pting ventricular myocyte intercalated disk (ID) nanodomains rich in cardiac sodium channels (Na(V)1.

135 ndividuals affected by imprinting disorders (IDs) displays multi-locus imprinting disturbances (MLID)

136 ) on a single-chip based on inkjet dispense (ID-SERS).

137 rial arrhythmia susceptibility by disrupting ID nanodomains and slowing atrial conduction.

138 e individuals with high peak infective dose (ID(50) > 10,000) maintained neutralizing antibody titres

139 aried between 11% and 56% of injected dose (%ID) or between 1.8 and 10.5 %ID/1,000 mL of bone volume

140 [LV] volume), and percentage injected dose (%ID) were calculated, and visual grading was performed.

141 ith 30.8 +/- 12.6 percentage injected dose (%ID)/g at 1 h after injection.

142 and liver uptake (percentage injected dose [%ID]) reached 15.37 +/- 5.21 %ID g(-1) and 6.56 +/- 4.03

143 ke (23.1 +/- 6.11 percentage injected dose [%ID]/g at 1 h after injection).

144 y 3 (10.5 +/- 4.1 percentage injected dose [%ID]/g vs. 3.8 +/- 0.9 %ID/g, P < 0.001) and on day 7 (7.

145 Intradialytic exercise (ID) programs are effective and safe for hemodialysis (HD

146 FHbp ID 896 is a member of the variant group 1 (subfamily B),

147 FHbp ID 896 of the clade was recognized by antibodies elicite

148 Interestingly, expression of FHbp ID 896 resulted in augmented killing of the clade by LL-

149 cceptable levels were 40% for IM and 50% for ID 2-dose schedule, and 70% for IM and 60% for ID 3-dose

150 2-dose schedule, and 70% for IM and 60% for ID 3-dose schedule.

151 ano-11 and cdAMP is a promising adjuvant for ID delivery of vaccines that supports a balanced immune

152 Key issues include funding for ID/HIV programs; the protection of public health and acc

153 s by organism ranged from 29.2 to 43.9 h for ID and from 47.9 to 73.9 h for AST.

154 8 to 51.7 h) and 60.5 h (46.6 to 72.4 h) for ID and AST, respectively.

155 and IDSA volunteer experiences, passion for ID, and working with IDSA staff to advance the programs

156 es for IDSA to Endorse as Best Practices for ID Divisions.

157 eID), there were 73 patients transferred for ID consults, while 171 patients were seen via teleID onc

158 itively correlated with LVMI (r = 0.485 for %ID) and strongly positively correlated, albeit in a smal

159 largest standardized effect was 0.485, for %ID.

160 Similar results were obtained for %ID/L and SUV(mean) SUV(max) did not correlate with survi

161 response was observed following needle-free ID immunization of pigs.

162 is showed that NPCs and neurons derived from ID patients have extensive deregulation of gene expressi

163 NTR5436 (August 3, 2015), ClinicalTrials.gov ID: NCT02701166 (March 2, 2016).

164 ssected, percentage injected dose per gram (%ID/g) was determined, and dosimetry was calculated using

165 ement article [1], it is requested the grant ID in the Funding section should be corrected from NSF g

166 adults assigned to 1 of 6 treatment groups (ID vs intramuscular [IM], 2 vs 3 doses, and controls), r

167 GsmPlot can simply accept GSM IDs to automatically download NCBI data or can accept us

168 HLA-ID LDKTx have less inflammation and less transplant glom

169 a retrospective, cohort study comparing HLA-ID sibling LDKTx (n=175) to HLA non-ID LDKTx (n=175; mat

170 matched siblings (termed HLA-identical (HLA-ID)) to HLA non-ID to investigate which histologic chang

171 Mortality rates were similar, but in the HLA-ID group, 10-year death-censored graft survival was high

172 opy structure of the monoubiquitinated human ID complex bound to DNA, and reveal that it forms a clos

173 Acid hydrolysis-ID-LC-MS/MS provides excellent quantitative selectivity

174 Identification (ID) and antimicrobial susceptibility testing (AST) of re

175 the lack of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resul

176 Although rapid pathogen-identification (ID) tests are being developed, gold-standard antibiotic

177 ction system (AXDX) provides identification (ID) and antimicrobial susceptibility testing (AST) resul

178 ridization for rapid species identification (ID) and morphokinetic bacterial analysis for phenotypic

179 Visual identification (ID) of species is subjective and usually requires substa

180 s to ensure high-confidence identifications (IDs).

181 o understand the role of IMPA1 deficiency in ID, we generated induced pluripotent stem cells (iPSCs)

182 We compared this adjusted difference in ID to that of peer subspecialties.

183 ers to academic advancement among faculty in ID and offer policy suggestions to narrow this gap.

184 This difference was greater in ID than in cardiology.

185 urate with the expansion of opportunities in ID, pathways to leadership positions within the Infectio

186 ude mentorship, networking, participation in ID and IDSA volunteer experiences, passion for ID, and w

187 pectrum antimicrobial utilization, increased ID consultations, and reduced antimicrobial expenditures

188 ations are performed by shuffling individual IDs of the genotype vector for this dataset, to preserve

189 ency virus and hepatitis C virus infections, ID physicians have unique expertise in addressing both t

190 , extrinsic factors significantly influenced ID MMEs, with seasonality linked to frequency (chi(2) =

191 nts who received outpatient ID intervention (ID-led OPAT) were matched 1-to-1 with those who did not

192 Intradermal (ID) immunization is an attractive route of vaccination b

193 Health Organization recommends intradermal (ID) administration of rabies vaccine for preexposure pro

194 rtonicity, resulting in stabilization of its ID regions.

195 ties allow users to access data via keyword, ID and advanced options combination search in an efficie

196 plete rearrangement of the open, trough-like ID structure through the ubiquitin of one protomer bindi

197 e recently been identified to cause X-linked ID in males, with heterozygous females typically having

198 his particular nonsyndromic form of X-linked ID.

199 Local ID consultations were tracked and antimicrobial cost sav

200 A simple topological feature, the local ID, is thus sufficient to achieve an unsupervised segmen

201 to discriminate regions with different local IDs and segment the points accordingly.

202 or associate) among female compared to male ID physicians was large and significant (absolute adjust

203 Mandatory ID consultation and PPRF for meropenem and imipenem beyo

204 Many ID physicians have incorporated the management of addict

205 a 2% coefficient of variation for SUV(max), %ID, and CAA and 3.8% for SUV(mean) All 4 quantitative me

206 uals with GEFD1 variants, who display milder ID and microcephaly.

207 Infectious disease-induced MMEs (ID MMEs) have not been reported ubiquitously among marin

208 cal data-indicate that the monoubiquitinated ID complex loses its preference for ICL and related bran

209 ring HLA-ID sibling LDKTx (n=175) to HLA non-ID LDKTx (n=175; matched for age, sex and year of transp

210 survival was higher (93.8% vs 80.9% HLA non-ID LDKTx, p<0.001), rejection rates were lower (after 1

211 s (termed HLA-identical (HLA-ID)) to HLA non-ID to investigate which histologic changes were likely d

212 This article discusses the advocacy of ID/HIV physicians and other healthcare professionals in

213 Interestingly, similar disruption of ID nanodomains has been identified in atrial samples fro

214 ch opportunities; and advancing the field of ID/HIV, including supporting the next generation of ID/H

215 including supporting the next generation of ID/HIV clinicians.

216 ides case studies illustrating the impact of ID/HIV physician advocacy.

217 Monoubiquitination of ID is essential for ICL repair by excision, translesion

218 The EIN is a sentinel network of ID physicians who care for adult and/or pediatric patien

219 We assess the occurrence of ID MMEs (1955-2018) across extant marine mammals (n = 12

220 ation was detected between the occurrence of ID MMEs and host characteristics, such as sociality or t

221 tory mandate supporting the participation of ID-trained physicians in IP programs.

222 oratories negatively impacts the practice of ID physicians, potentially delays effective implementati

223 We define the potential role of ID/addiction physicians in clinical care, health adminis

224 Use of ID in determining transplant candidacy may stem partly f

225 dy was to compare the effects of 16 weeks of ID exercise versus a HB exercise program for HD patients

226 ay and/or intellectual disability (DD and/or ID) disease phenotypes.

227 15 unrelated individuals who have DD and/or ID, central nervous system (CNS) dysfunction, vertebral

228 failure (cardiac death, target-vessel MI, or ID-TLR) were assessed within year 1 and between 1 and 5

229 NFAT5 has three intrinsically ordered (ID) activation domains (ADs).

230 specimen collection to reporting of organism ID/AST were evaluated and compared by specimen types and

231 ty scoring, patients who received outpatient ID intervention (ID-led OPAT) were matched 1-to-1 with t

232 and showed a slight improvement in PPA over ID NOW.

233 tinuously updated with an anonymized patient ID, the J-CKD-DB will be a dynamic registry of Japanese

234 g on the creation of a unique global patient ID that can integrate data from a variety of healthcare

235 e of the MO-matrix grown A(2A)R crystal (PDB ID: 4EIY).

236 es >1,000 at >60 d POS, some with lower peak ID(50) had neutralizing antibody titres approaching base

237 ) and barcode strain identification (Plasmid ID) through next generation sequencing (NGS).

238 Primer ID deep sequencing of the V1/V3 region of the HIV-1 env

239 A combination of Primer-ID and deep sequencing is a promising approach that may

240 their relative proportions using the Primer-ID based, quantitative single-variant sequencing (qSVS)

241 However, most studies that used the Primer-ID method have analyzed clinical samples directly.

242 ther evaluating the confidence of proteoform IDs after the database search.

243 ally via digital object identifier or PubMed ID.

244 te persistent identifiers (e.g. DOIs, PubMed IDs, ISBNs, URLs), whose metadata is then retrieved and

245 Netherlands Trial Register, ID: NTR5436 (August 3, 2015), ClinicalTrials.gov ID: NCT

246 This study is registered, ID-code NCT00591695.

247 nd the GRADE approach (Prospero registration ID: CRD42019120363).

248 emia-driven target lesion revascularization [ID-TLR]) as well as its individual components at 5 years

249 emia-driven target lesion revascularization [ID-TLR]), and target lesion failure (cardiac death, targ

250 (Prospective Register of Systematic Reviews ID: CRD42018117255) was undertaken on December 8, 2018,

251 mias by dynamically disrupting Na(V)1.5-rich ID nanodomains and slowing atrial conduction.

252 st, and point-of-care tests such as Abbott's ID NOW COVID-19 Test.

253 e seventh spectrin repeat have a more severe ID associated with macrocephaly than do most individuals

254 activates the transcription of the BMP-SMAD-ID signaling pathway, which may be responsible for promo

255 These TG2-specific IDs were used to identify potential anti-IDs in the seru

256 nductively coupled plasma mass spectrometry (ID-CV-ICP-MS) and laser absorption spectroscopy (LAS).

257 esistance Associated-interacting domain (SRA-ID), but not the membrane-addressing domain (MAD), being

258 Other study ID numbers: SleepDep 02/14.

259 , 2018; Ethics Committee approved the study (ID: 1.790.088) on October 25th, 2016.

260 ent trends regarding the use of telemedicine ID (teleID) consults as an adjunct to the standard of ca

261 We believe that ID-SERS paves the way for the development of reproducibl

262 Our results show that ID MMEs have been reported in 14% of marine mammal speci

263 The ID complex, involving the proteins FANCI and FANCD2, is

264 The ID Now influenza A & B 2 (ID Now) assay (Abbott Laborato

265 sed to determine transplant eligibility, the ID criterion remains controversial because of its potent

266 The overall sensitivities for the ID Now assay, LIAT, and Xpert assay for Flu A virus dete

267 (2); this triggers monoubiquitination of the ID complex, in which one ubiquitin molecule is conjugate

268 on studies help validate the accuracy of the ID-CV-ICP-MS primary method as well as establish the LAS

269 o a more diffuse distribution throughout the ID.

270 of 46 patients were randomly assigned to the ID group (n = 24) or HB group (n = 22).

271 common intuition, there are cases where the ID varies within the same data set.

272 lu A/B virus positive, 2 samples), while the ID Now virus detected 102 samples (Flu A virus, 69 sampl

273 to give a name and define the role of these ID/addiction dual specialists.

274 of injected dose per gram of brain tissue (%ID/g) in the cortex and 17.09 +/- 7.22%ID/g in subcortic

275 ercentage injected dose per gram of tissue [%ID/g]) than of [(68)Ga]Ga-FAPI-04 (2 %ID/g).

276 reduction was observed during DB compared to ID (P = 0.043).

277 e positive %DeltasVR (P < 0.001) compared to ID.

278 and high error rates for AD in comparison to ID-BMD.

279 ignificantly enhanced the immune response to ID-injected vaccines in mice and pigs with minimal local

280 nificantly decreased time from Gram stain to ID (median, 23 vs 2.2 hours, P < .001) and AST (median,

281 Use of ADX significantly reduced time to ID and AST as well as time to optimal antimicrobial ther

282 nical Trials Registry (ANZCTR.org.au), trial ID 108 ACTRN12618000112268/U1111-1207-3550.

283 nese Clinical Trial Registry (ChiCTR); Trial ID: ChiCTR1800018645.

284 ing algorithm to identify the potential true IDs based on data relationships of multi-omics.

285 with the structure of the non-ubiquitinated ID complex bound to ICL DNA-which we also report here-we

286 teome can also be retrieved by their UniProt IDs.

287 dly cleared, leading to lower tumor uptake (%ID/g) and decreased in vivo efficacy.

288 bent tubes to be subsequently analyzed using ID-CV-ICP-MS.

289 However, using ID as a contraindication to solid organ transplantation

290 We examine the benefits and harms of using ID as a transplant eligibility criterion, review current

291 n 1.8 and 10.5 %ID/1,000 mL of bone volume (%ID/L).

292 press (~46 min) and ePlex (~1.5 h), but what ID NOW gained in rapid results, it lost in analytical an

293 ir access to transplant for individuals with ID.

294 (CNVs), have been reported in patients with ID and other related NDDs.

295 rse adherence and outcomes for patients with ID, fear of penalties to transplant centers for poor out

296 rounding the quality of life for people with ID.

297 remote hospital site who were provided with ID consultations, either in person, via teleID, or both.

298 n one family the duplication segregated with ID across three generations.

299 achieving the rank of full professor within ID.

300 evaluated the performance of the Vitek 2 YST ID card to identify C. auris and related species.